Pfizer (BUE:PFE) Other Long Term Assets : ARS13,597,108 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Pfizer Other Long Term Assets?

Pfizer's other long-term assets for the quarter that ended in Mar. 2024 was ARS13,597,108 Mil.

Pfizer's quarterly other long-term assets declined from Sep. 2023 (ARS6,004,442 Mil) to Dec. 2023 (ARS5,839,897 Mil) but then increased from Dec. 2023 (ARS5,839,897 Mil) to Mar. 2024 (ARS13,597,108 Mil).

Pfizer's annual other long-term assets increased from Dec. 2021 (ARS1,113,011 Mil) to Dec. 2022 (ARS3,329,194 Mil) and increased from Dec. 2022 (ARS3,329,194 Mil) to Dec. 2023 (ARS5,839,897 Mil).

Pfizer Other Long Term Assets Historical Data

The historical data trend for Pfizer's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Other Long Term Assets Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

1,167,796.82

591,062.92

1,113,010.77

3,329,193.61

5,839,897.01

Pfizer Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															4,003,745.94	5,109,119.96	6,004,442.27	5,839,897.01	13,597,107.73

Pfizer Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Pfizer (BUE:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (BUE:PFE) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.